While the relationship between GNAS mutations and the aggressive growth of PAs remains incompletely understood, studies have shown that GH‐PAs with GNAS mutations often exhibit unique clinical features, including older patient age, relatively smaller tumor size, lower tendency for aggressive growth, and a histologically dense‐grained morphology [47]. This evidence concerns the gene GH1 and neoplasm.